De novo lung biofabrication: clinical need, construction methods, and design strategy

Translational Research - Tập 211 - Trang 1-18 - 2019
Erica M. Comber1, Rachelle N. Palchesko1, Wai Hoe NG1, Xi Ren1, Keith E. Cook1
1Department of Biomedical Engineering, Carnegie Mellon University, Pittsburgh, Pennsylvania

Tài liệu tham khảo

2012 Esposito, 2015, Idiopathic pulmonary fibrosis in united states automated claims. Incidence, prevalence, and algorithm validation, Am J Respir Crit Care Med, 192, 1200, 10.1164/rccm.201504-0818OC Coultas, 1994, The epidemiology of interstitial lung diseases, Am J Respir Crit Care Med, 150, 967, 10.1164/ajrccm.150.4.7921471 Cystic Fibrosis Foundation. About cystic fibrosis. https://www.cff.org/What-is-CF/About-Cystic-Fibrosis/. Published 2018, accessed December 1, 2018. Center for Health Statistics N. National Hospital Ambulatory Medical Care Survey: 2014 Emergency Department Summary Tables. http://www.cdc.gov/nchs/ahcd/ahcd_survey_instruments.htm#nhamcs, accessed January 30, 2019. United Network for Organ Sharing. Technology for transplantation – 2017; 2018. https://unos.org/data/transplant-trends/, accessed July 4, 2018. Valapour, 2019, OPTN/SRTR 2017 annual data report: lung, Am J Transplant, 19, 404, 10.1111/ajt.15279 Makdisi, 2017, Ex vivo lung perfusion review of a revolutionary technology, Ann Transl Med, 5, 343, 10.21037/atm.2017.07.17 Machuca, 2014, Ex vivo lung perfusion, J Thorac Dis, 6, 1054 Valapour, 2017, OPTN/SRTR 2015 annual data report: lung, Am J Transplant, 17, 357, 10.1111/ajt.14129 Valapour, 2018, OPTN/SRTR 2016 annual data report: lung, Am J Transplant, 18, 363, 10.1111/ajt.14562 UCSF Medical Center. Lung transplant preparation. https://www.ucsfhealth.org/conditions/lung_transplant/signs_and_symptoms.html. Published2018, accessed July 9, 2018. Colvin-Adams, 2012, Lung and heart allocation in the United States, Am J Transplant, 12, 3213, 10.1111/j.1600-6143.2012.04258.x Suissa, 2012, Long-term natural history of chronic obstructive pulmonary disease: severe exacerbations and mortality, Thorax, 67, 957, 10.1136/thoraxjnl-2011-201518 Donaldson, 2002, Relationship between exacerbation frequency and lung function decline in chronic obstructive pulmonary disease, Thorax, 57, 847, 10.1136/thorax.57.10.847 Yusen, 2013, The registry of the international society for heart and lung transplantation: thirtieth adult lung and heart-lung transplant report—2013; focus theme: age, J Hear Lung Transplant, 32, 965, 10.1016/j.healun.2013.08.007 Ley, 2011, Clinical course and prediction of survival in idiopathic pulmonary fibrosis, Am J Respir Crit Care Med, 183, 431, 10.1164/rccm.201006-0894CI U.S. Department of Health and Human Services. United States Organ Transplantation: OPTN/SRTR 2012 annual data report; 2014. https://srtr.transplant.hrsa.gov/annual_reports/2012/pdf/2012_SRTR_ADR.pdf, accessed December 1, 2018. Vogelmeier, 2017, Global strategy for the diagnosis, management, and prevention of chronic obstructive lung disease 2017 report. GOLD executive summary, Am J Respir Crit Care Med, 195, 557, 10.1164/rccm.201701-0218PP Percival, 2015, Healthcare-associated infections, medical devices and biofilms: risk, tolerance and control, J Med Microbiol, 64, 323, 10.1099/jmm.0.000032 Hunter, 2001, COPD: management of acute exacerbations and chronic stable disease, Am Fam Phys, 64, 603 Schwarz, 2003 Smith, 2011, Treatment of pulmonary exacerbations in cystic fibrosis, Fut Med, 8, 623 Global Initiative for Chronic Obstructive Pulmonary Disease. Global strategy for the diagnosis, management, and prevention of chronic obstructive pulmonary disease (2018 Report). 2018. https://goldcopd.org/wp-content/uploads/2017/11/GOLD-2018-v6.0-FINAL-revised-20-Nov_WMS.pdf, accessed June 8, 2018. Rana, 2006, Failure of non-invasive ventilation in patients with acute lung injury: observational cohort study, Crit Care, 10, R79, 10.1186/cc4923 Brochard, 1995, Noninvasive ventilation for acute exacerbations of chronic obstructive pulmonary disease, N Engl J Med, 333, 817, 10.1056/NEJM199509283331301 Faverio, 2018, Management of acute respiratory failure in interstitial lung diseases: overview and clinical insights, BMC Pulm Med, 18, 70, 10.1186/s12890-018-0643-3 Levine, 1991, The impact of tracheal intubation on host defenses and risks for nosocomial pneumonia, Clin Chest Med, 12, 523, 10.1016/S0272-5231(21)00800-5 Bhowmik, 2009, Improving mucociliary clearance in chronic obstructive pulmonary disease, Respir Med, 103, 496, 10.1016/j.rmed.2008.10.014 Robinson, 2000, Regional Mucociliary clearance in patients with cystic fibrosis, J Aerosol Med, 13, 73, 10.1089/089426800418604 Lone, 2011, Prolonged mechanical ventilation in critically ill patients: epidemiology, outcomes and modelling the potential cost consequences of establishing a regional weaning unit, Crit Care, 15, R102, 10.1186/cc10117 Loss, 2015, The reality of patients requiring prolonged mechanical ventilation: a multicenter study, Rev Bras Ter Intensiva, 27, 26, 10.5935/0103-507X.20150006 Naito, 2018, Artificial lungs for lung failure: JACC Technology Corner, J Am Coll Cardiol, 72, 1640, 10.1016/j.jacc.2018.07.049 Gattinoni, 2011, Clinical review: extracorporeal membrane oxygenation, Crit Care, 15, 243, 10.1186/cc10490 Federspiel WJ, HKA, Lung, Artificial: basic principles andcurrent applications. Encycl Biomater Biomed Eng. 2004:910–921. doi:10.1081/E-EBBE Mosier, 2015, Extracorporeal membrane oxygenation (ECMO) for critically ill adults in the emergency department: history, current applications, and future directions, Crit Care, 10.1186/s13054-015-1155-7 Dalton, 2015, Association of bleeding and thrombosis with outcome in extracorporeal life support, Pediatr Crit Care Med, 16, 167, 10.1097/PCC.0000000000000317 Mazzeffi, 2016, Bleeding, transfusion, and mortality on extracorporeal life support: ECLS working group on thrombosis and hemostasis, Ann Thorac Surg, 101, 682, 10.1016/j.athoracsur.2015.07.046 Kuehn, 2013, Microbial adhesion on membrane oxygenators in patients requiring extracorporeal life support detected by a universal rDNA PCR test, ASAIO J, 59, 368, 10.1097/MAT.0b013e318299fd07 Haneya, 2011, Extracorporeal circulatory systems as a bridge to lung transplantation at remote transplant centers, Ann Thorac Surg, 91, 250, 10.1016/j.athoracsur.2010.09.005 Camboni, 2009, First experience with a paracorporeal artificial lung in humans, ASAIO J, 55, 304, 10.1097/MAT.0b013e31819740a0 Fischer, 2006, Bridge to lung transplantation with the novel pumpless interventional lung assist device NovaLung, J Thorac Cardiovasc Surg, 131, 719, 10.1016/j.jtcvs.2005.10.050 Strueber, 2009, Bridge to thoracic organ transplantation in patients with pulmonary arterial hypertension using a pumpless lung assist device, Am J Transplant, 9, 853, 10.1111/j.1600-6143.2009.02549.x Bradley, 1980, Chapter 3 the fibroblast of human lung alveolar structures: a differentiated cell with a major role in lung structure and function, Methods Cell Biol, 21, 37, 10.1016/S0091-679X(08)60757-8 Brogan, 2012, Prolonged extracorporeal membrane oxygenation for children with respiratory failure, Pediatr Crit Care Med, 13, e249, 10.1097/PCC.0b013e31824176f4 Jackson, 2008, Use of extracorporeal membrane oxygenation as a bridge to primary lung transplant: 3 consecutive, successful cases and a review of the literature, J Heart Lung Transplant, 27, 348, 10.1016/j.healun.2007.12.006 Fischer, 2007, Bridge to lung transplantation with the extracorporeal membrane ventilator Novalung in the veno-venous mode: the initial Hannover experience, ASAIO J, 53, 168, 10.1097/MAT.0b013e31802deb46 Mulholland, 2005, Blood flow and damage by the roller pumps during cardiopulmonary bypass, J Fluids Struct, 20, 129, 10.1016/j.jfluidstructs.2004.10.008 Bartosik, 2011, The Novalung interventional lung assist as bridge to lung transplantation for self-ventilating patients – initial experience, Interact Cardiovasc Thorac Surg, 13, 198, 10.1510/icvts.2011.266346 Zwischenberger, 2002, Artificial lungs: a new inspiration, Perfusion, 17, 253, 10.1191/0267659102pf586oa Amoako, 2013, Fabrication and in vivo thrombogenicity testing of nitric oxide generating artificial lungs, J Biomed Mater Res Part A, 101, 3511, 10.1002/jbm.a.34655 Skoog, 2017, Fourteen day in vivo testing of a compliant thoracic artificial lung, ASAIO J, 63, 644, 10.1097/MAT.0000000000000627 Amoako, 2016, Multimodal, biomaterial-focused anticoagulation via superlow fouling zwitterionic functional groups coupled with anti-platelet nitric oxide release, Adv Mater Interfaces, 3, 10.1002/admi.201500646 Sundaram, 2014, Achieving one-step surface coating of highly hydrophilic poly(carboxybetaine methacrylate) polymers on hydrophobic and hydrophilic surfaces, Adv Mater Interfaces, 1, 10.1002/admi.201400071 Malkin, 2018, Development of zwitterionic sulfobetaine block copolymer conjugation strategies for reduced platelet deposition in respiratory assist devices, J Biomed Mater Res Part B Appl Biomater, 106, 2681, 10.1002/jbm.b.34085 Ye, 2015, Hollow fiber membrane modification with functional zwitterionic macromolecules for improved thromboresistance in artificial lungs, Langmuir, 31, 2463, 10.1021/la504907m Wiegmann, 2016, Developing a biohybrid lung - sufficient endothelialization of poly-4-methly-1-pentene gas exchange hollow-fiber membranes, J Mech Behav Biomed Mater, 10.1016/j.jmbbm.2016.01.032 Hess, 2010, Reduced thrombocyte adhesion to endothelialized poly 4-methyl-1-pentene gas exchange membranes—a first step toward bioartificial lung development, Tissue Eng Part A, 16, 3043, 10.1089/ten.tea.2010.0131 Alvarado, 2016, Metabolic functions of the lung, disorders and associated pathologies, J Clin Med Res, 8, 689, 10.14740/jocmr2668w Jagger T.W., Van Brunt N.P., Kivisto J.A., Lonnes P.B.Product pump for an oxygen concentrator. February 2005. https://patents.google.com/patent/US7171963B2/en, accessed March 30, 2019. Derya, 2014, The role of extracellular matrix in lung diseases, Biol Med, 06, 10.4172/0974-8369.1000200 Rosso, 2004, From Cell-ECM interactions to tissue engineering, J Cell Physiol, 199, 174, 10.1002/jcp.10471 West, 2003, Thoughts on the pulmonary blood-gas barrier, Am J Physiol Cell Mol Physiol, 285, L501, 10.1152/ajplung.00117.2003 Sheehy, 2018, Collagen-based biomaterials for tissue regeneration and repair, Pept Proteins as Biomater Tissue Regen Repair, 127, 10.1016/B978-0-08-100803-4.00005-X Parenteau-Bareil, 2010, Collagen-based biomaterials for tissue engineering applications, Materials (Basel), 10.3390/ma3031863 Huh, 2012, A human disease model of drug toxicity–induced pulmonary edema in a lung-on-a-chip microdevice, Sci Transl Med, 4, 10.1126/scitranslmed.3004249 Morgan, 2019, Fabrication of centimeter-scale and geometrically arbitrary vascular networks using in vitro self-assembly, Biomaterials, 189, 37, 10.1016/j.biomaterials.2018.10.021 Vernon, 2005, Native fibrillar collagen membranes of micron-scale and submicron thicknesses for cell support and perfusion, Biomaterials, 26, 1109, 10.1016/j.biomaterials.2004.04.019 Golden, 2007, Fabrication of microfluidic hydrogels using molded gelatin as a sacrificial element, Lab Chip, 7, 720, 10.1039/b618409j Kang, 2006, Novel porous gelatin scaffolds by overrun/particle leaching process for tissue engineering applications, J Biomed Mater Res Part B Appl Biomater, 79B, 388, 10.1002/jbm.b.30553 Phull, 2013, Novel macro-microporous gelatin scaffold fabricated by particulate leaching for soft tissue reconstruction with adipose-derived stem cells, J Mater Sci Mater Med, 24, 461, 10.1007/s10856-012-4806-0 Wang, 2014, Engineering interconnected 3D vascular networks in hydrogels using molded sodium alginate lattice as the sacrificial template, Lab Chip, 14, 2709, 10.1039/C4LC00069B Chang, 2001, Injection molding of chondrocyte/alginate constructs in the shape of facial implants, J Biomed Mater Res, 55, 503, 10.1002/1097-4636(20010615)55:4<503::AID-JBM1043>3.0.CO;2-S Palchesko, 2016, Engineered basement membranes for regenerating the corneal endothelium, Adv Healthc Mater, 10.1002/adhm.201600488 Canavan, 2005, Cell sheet detachment affects the extracellular matrix: a surface science study comparing thermal liftoff, enzymatic, and mechanical methods, J Biomed Mater Res Part A, 75A, 1, 10.1002/jbm.a.30297 da Silva, 2007, Smart thermoresponsive coatings and surfaces for tissue engineering: switching cell-material boundaries, Trends Biotechnol, 25, 577, 10.1016/j.tibtech.2007.08.014 Bellan, 2009, Fabrication of an artificial 3-dimensional vascular network using sacrificial sugar structures, Soft Matter, 5, 1354, 10.1039/b819905a Kolesky, 2014, 3D bioprinting of vascularized, heterogeneous cell-laden tissue constructs, Adv Mater, 26, 3124, 10.1002/adma.201305506 Nazhat, 2007, Controlled microchannelling in dense collagen scaffolds by soluble phosphate glass fibers, Biomacromolecules, 8, 543, 10.1021/bm060715f Murphy, 2014, 3D bioprinting of tissues and organs, Nat Biotechnol, 32, 773, 10.1038/nbt.2958 Mandrycky, 2016, 3D bioprinting for engineering complex tissues, Biotechnol Adv, 34, 422, 10.1016/j.biotechadv.2015.12.011 Hospodiuk, 2017, The bioink: a comprehensive review on bioprintable materials, Biotechnol Adv, 35, 217, 10.1016/j.biotechadv.2016.12.006 Munaz, 2016, Three-dimensional printing of biological matters, J Sci Adv Mater Devices, 1, 1, 10.1016/j.jsamd.2016.04.001 Hinton, 2015, Three-dimensional printing of complex biological structures by freeform reversible embedding of suspended hydrogels, Sci Adv, 1, 10.1126/sciadv.1500758 Hinton, 2017, 3D bioprinting from the micrometer to millimeter length scales: size does matter, Curr Opin Biomed Eng, 1, 31, 10.1016/j.cobme.2017.02.004 Ward, 1984, Alveolar type I and type II cells, Aust N Z J Med, 14, 731, 10.1111/j.1445-5994.1984.tb04928.x Castranova, 1988, The alveolar type II epithelial cell: a multifunctional pneumocyte, Toxicol Appl Pharmacol, 93, 472, 10.1016/0041-008X(88)90051-8 Barkauskas, 2013, Type 2 alveolar cells are stem cells in adult lung, J Clin Invest, 123, 3025, 10.1172/JCI68782 Garcia, 2016, Targeted type 2 alveolar cell depletion. A dynamic functional model for lung injury repair, Am J Respir Cell Mol Biol, 54, 319, 10.1165/rcmb.2014-0246OC Kalina, 1992, Surfactant protein C is expressed in alveolar type II cells but not in Clara cells of rat lung, Am J Respir Cell Mol Biol, 6, 594, 10.1165/ajrcmb/6.6.594 Mao, 2015, Human alveolar epithelial type II cells in primary culture, Physiol Rep, 3, e12288, 10.14814/phy2.12288 Zacharias, 2018, Isolation and culture of human alveolar epithelial progenitor cells, Protoc Exch, 10.1038/protex.2018.015 Witherden, 2001, Isolation and culture of human alveolar type II pneumocytes, 56, 137 Elbert, 1999, Monolayers of human alveolar epithelial cells in primary culture for pulmonary absorption and transport studies, Pharm Res, 16, 601, 10.1023/A:1018887501927 Fujino, 2011, Isolation of alveolar epithelial type II progenitor cells from adult human lungs, Lab Investig, 91, 363, 10.1038/labinvest.2010.187 Dobbs, 1990, Isolation and culture of alveolar type II cells, Am J Physiol Cell Mol Physiol, 258, L134, 10.1152/ajplung.1990.258.4.L134 Hermanns, 2004, Lung epithelial cell lines in coculture with human pulmonary microvascular endothelial cells: development of an alveolo-capillary barrier in vitro, Lab Investig, 84, 736, 10.1038/labinvest.3700081 Foster, 1998, Characterization of the A549 cell line as a type ii pulmonary epithelial cell model for drug metabolism, Exp Cell Res, 243, 359, 10.1006/excr.1998.4172 Corbière, 2011, Phenotypic characteristics of human type II alveolar epithelial cells suitable for antigen presentation to T lymphocytes, Respir Res, 12, 15, 10.1186/1465-9921-12-15 Takano, 2015, Functional Expression of PEPT2 in the Human Distal Lung Epithelial Cell Line NCl-H441, Pharm Res, 32, 3916, 10.1007/s11095-015-1751-x Rehan, 2002, 1α,25-Dihydroxy-3-epi-vitamin D3, a natural metabolite of 1α,25-dihydroxy vitamin D3: production and biological activity studies in pulmonary alveolar type II cells, Mol Genet Metab, 76, 46, 10.1016/S1096-7192(02)00022-7 Ren, 2016, An optimised human cell culture model for alveolar epithelial transport, PLoS One, 11, 10.1371/journal.pone.0165225 Salomon, 2014, The Cell line NCl-H441 is a useful in vitro model for transport studies of human distal lung epithelial barrier, Mol Pharm, 11, 995, 10.1021/mp4006535 Dekali, 2014, Assessment of an in vitro model of pulmonary barrier to study the translocation of nanoparticles, Toxicol Reports, 1, 157, 10.1016/j.toxrep.2014.03.003 Jacob, 2017, Differentiation of human pluripotent stem cells into functional lung alveolar epithelial cells, Cell Stem Cell, 21, 472, 10.1016/j.stem.2017.08.014 Chen, 2017, A three-dimensional model of human lung development and disease from pluripotent stem cells, Nat Cell Biol, 19, 542, 10.1038/ncb3510 Vascular bed-specific thrombosis.https://onlinelibrary.wiley.com/doi/pdf/10.1111/j.1538-7836.2007.02515.x, accessed August 13, 2018. Aird, 2007, Phenotypic Heterogeneity of the Endothelium: I. Structure, Function, and Mechanisms, Circ Res, 100, 158, 10.1161/01.RES.0000255691.76142.4a Nolan, 2013, Molecular signatures of tissue-specific microvascular endothelial cell heterogeneity in organ maintenance and regeneration, Dev Cell, 26, 204, 10.1016/j.devcel.2013.06.017 Lippmann, 2012, Derivation of blood-brain barrier endothelial cells from human pluripotent stem cells, Nat Biotechnol, 30, 783, 10.1038/nbt.2247 Watson, 2014, An in vivo model of human small intestine using pluripotent stem cells, Nat Med, 20, 1310, 10.1038/nm.3737 Dye, 2015, In vitro generation of human pluripotent stem cell derived lung organoids, Elife, 4, 10.7554/eLife.05098 Melero-Martin, 2008, Engineering robust and functional vascular networks in vivo with human adult and cord blood–derived progenitor cells, Circ Res, 103, 194, 10.1161/CIRCRESAHA.108.178590 Au, 2008, Bone marrow-derived mesenchymal stem cells facilitate engineering of long-lasting functional vasculature, Blood, 111, 4551, 10.1182/blood-2007-10-118273 Newhouse, 1999, Tennis anyone? The lungs as a new court for systemic therapy, CMAJ, 161, 1287 Ochs, 2004, The Number of Alveoli in the Human Lung, Am J Respir Crit Care Med, 169, 120, 10.1164/rccm.200308-1107OC Gehr, 1978, The normal human lung: ultrastructure and morphometric estimation of diffusion capacity, Respir Physiol, 32, 121, 10.1016/0034-5687(78)90104-4 Fung, 1990, Blood Flow in Heart, Lung, Arteries, and Veins, 155 Galletti, 1971, Applications of plastics in membrane oxygenators, J Biomed Mater Res, 5, 129, 10.1002/jbm.820050213 Trahanas, 2016, Treating Lungs&quot: The scientific contributions of Dr. Theodor Kolobow, ASAIO J, 62, 203, 10.1097/MAT.0000000000000323 Stewart, 1968, Short-term hemodialysis with the capillary kidney, Trans Am Soc Artif Intern Organs, 14, 121 Stewart, 1968, Hemodialysis with the capillary kidney, Univ Mich Med Cent J, 34, 80 Pettenuzzo, 2018, Extracorporeal carbon dioxide removal in acute exacerbations of chronic obstructive pulmonary disease, Ann Transl Med, 6, 31, 10.21037/atm.2017.12.11 West, 2008 Noone, 2008, Non-invasive ventilation for the treatment of hypercapnic respiratory failure in cystic fibrosis, Thorax, 63, 5, 10.1136/thx.2007.086710 Madden, 2002, Noninvasive ventilation in cystic fibrosis patients with acute or chronic respiratory failure, Eur Respir J, 19, 310, 10.1183/09031936.02.00218502 Plantier, 2018, Physiology of the lung in idiopathic pulmonary fibrosis, Eur Respir Rev, 27, 10.1183/16000617.0062-2017 Asfar, 2015, Understanding the benefits and harms of oxygen therapy, Intensive Care Med, 41, 1118, 10.1007/s00134-015-3670-z Mach, 2011, Consequences of hyperoxia and the toxicity of oxygen in the lung, Nurs Res Pract, 2011 Chawla, 2001, Oxygen toxicity, Med J Armed Forces India, 57, 131, 10.1016/S0377-1237(01)80133-7 Mikic, 1972, Upper and lower bounds on oxygen transfer rates: a theoretical consideration, Ann Biomed Eng, 1, 212, 10.1007/BF02584208 Potkay, 2013, A simple, closed-form, mathematical model for gas exchange in microchannel artificial lungs, Biomed Microdevices, 15, 397, 10.1007/s10544-013-9736-1 Lee, 2008, Microchannel technologies for artificial lungs: (3) open rectangular channels, ASAIO J, 54, 390, 10.1097/MAT.0b013e31817eda02 Dunlop, 2010, Is oxygen toxic?, Evidence-Based Pract Crit Care, 45, 10.1016/B978-1-4160-5476-4.00008-0 Jackson, 1985, Pulmonary oxygen toxicity, Chest, 88, 900, 10.1378/chest.88.6.900 Van Hinsbergh, 2012, Endothelium – role in regulation of coagulation and inflammation, Semin Immunopathol, 10.1007/s00281-011-0285-5 Yau, 2015, Endothelial cell control of thrombosis, BMC Cardiovasc Disord, 10.1186/s12872-015-0124-z Kim, 2003, Protein transport across the lung epithelial barrier, Am J Physiol Cell Mol Physiol, 284, L247, 10.1152/ajplung.00235.2002 Chang, 2010, Alveolar epithelium in lung toxicology, Compr Toxicol, 59, 10.1016/B978-0-08-046884-6.00904-0 Bazzoni, 2006, Endothelial tight junctions: permeable barriers of the vessel wall, Thromb Haemost, 95, 36, 10.1160/TH05-07-0488 Gumbiner, 1993, Breaking through the tight junction barrier, J Cell Biol, 123, 1631, 10.1083/jcb.123.6.1631 Matthay, 2002, Lung epithelial fluid transport and the resolution of pulmonary edema, Physiol Rev, 82, 569, 10.1152/physrev.00003.2002 Huh, 2010, Reconstituting organ-level lung functions on a chip, Science, 328, 10.1126/science.1188302 Pezzulo A.A., Starner T.D., Scheetz T.E., et al. The air-liquid interface and use of primary cell cultures are important to recapitulate the transcriptional profile of in vivo airway epithelia. https://www.physiology.org/doi/pdf/10.1152/ajplung.00256.2010, accessed May 18, 2018. Dobbs, 1997, Maintenance of the differentiated type II cell phenotype by culture with an apical air surface, Am J Physiol, 273, L347 Bärnthaler, 2017, The role of PGE2 in alveolar epithelial and lung microvascular endothelial crosstalk, Sci Rep, 7, 7923, 10.1038/s41598-017-08228-y Wang, 2013, Human alveolar epithelial cells attenuate pulmonary microvascular endothelial cell permeability under septic conditions, PLoS One, 8, e55311, 10.1371/journal.pone.0055311 van Hinsbergh, 2012, Endothelium—role in regulation of coagulation and inflammation, Semin Immunopathol, 34, 93, 10.1007/s00281-011-0285-5 Cines, 1998, Endothelial cells in physiology and in the pathophysiology of vascular disorders, Blood, 91 Wu, 1996, Role of endothelium in thrombosis and hemostasis, Annu Rev Med, 47, 315, 10.1146/annurev.med.47.1.315 Chow, 1992, Shear stress-induced von Willebrand factor binding to platelet glycoprotein Ib initiates calcium influx associated with aggregation, Blood, 80, 10.1182/blood.V80.1.113.113 Chiu, 2011, Effects of disturbed flow on vascular endothelium: pathophysiological basis and clinical perspectives, Physiol Rev, 91, 327, 10.1152/physrev.00047.2009 Malek, 1999, Hemodynamic shear stress and its role in atherosclerosis, JAMA, 282, 2035, 10.1001/jama.282.21.2035 Brown, 2009, Characterization of umbilical cord blood-derived late outgrowth endothelial progenitor cells exposed to laminar shear stress, Tissue Eng Part A, 15, 3575, 10.1089/ten.tea.2008.0444 Sriram, 2016, Shear-induced nitric oxide production by endothelial cells, Biophys J, 111, 208, 10.1016/j.bpj.2016.05.034 Humphrey, 2014, Mechanotransduction and extracellular matrix homeostasis, Nat Rev Mol Cell Biol, 15, 802, 10.1038/nrm3896 Fredberg, 2006, Stress transmission in the lung: pathways from organ to molecule, Annu Rev Physiol, 68, 507, 10.1146/annurev.physiol.68.072304.114110 Knudsen, 2018, The micromechanics of lung alveoli: structure and function of surfactant and tissue components, Histochem Cell Biol, 1 Tschumperlin, 2000, Deformation-induced injury of alveolar epithelial cells, Am J Respir Crit Care Med, 162, 357, 10.1164/ajrccm.162.2.9807003 Mercer, 1987, Three-dimensional reconstruction of alveoli in the rat lung for pressure-volume relationships, J Appl Physiol, 62, 1480, 10.1152/jappl.1987.62.4.1480 Gil, 1979, Alveolar volume-surface area relation in air- and saline-filled lungs fixed by vascular perfusion, J Appl Physiol, 47, 990, 10.1152/jappl.1979.47.5.990 Dolinay, 2017, Integrated stress response mediates epithelial injury in mechanical ventilation, Am J Respir Cell Mol Biol, 57, 193, 10.1165/rcmb.2016-0404OC Lu, 2015, Tissue engineered constructs: perspectives on clinical translation, Ann Biomed Eng, 43, 796, 10.1007/s10439-015-1280-0 Golchin, 2019, Biological products: cellular therapy and FDA approved products, Stem Cell Rev Rep, 15, 166, 10.1007/s12015-018-9866-1